Publications by authors named "Ria Hawks"

Claim this Profile
T
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients.
Prakash Satwani, Zhezhen Jin, Deirdre Duffy, Erin Morris, Monica Bhatia, Ria Hawks

Biol Blood Marrow Transplant· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
Prakash Satwani, Monica Bhatia, James H Garvin, Diane George, Filemon Dela Cruz, Ria Hawks

Biol Blood Marrow Transplant· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
Janice S Withycombe, Janice E Post-White, Jane L Meza, Ria G Hawks, Lynette M Smith

Pediatr Blood Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.
Ian M Waxman, Olga Militano, Leah Baldinger, Elizabeth Roman, Erin Qualter, Ria Hawks

Pediatr Transplant· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.
Elif Unal, Catherine Yen, Lisa Saiman, Diane George, Phyllis Della-Latta, Ria Hawks

Biol Blood Marrow Transplant· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and alternative medicine research initiatives in the Children's Oncology Group and the role of the pediatric oncology nurse.
Ria Hawks

J Pediatr Oncol Nurs· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future directions of CAM research in pediatric oncology.
Janice Post-White, Ria Hawks, Ann O'Mara, Mary Jane Ott

J Pediatr Oncol Nurs· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for symptom management in the child with cancer.
Elena J Ladas, Janice Post-White, Ria Hawks, Kathy Taromina

J Pediatr Hematol Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Paul S Gaynon, Richard E Harris, Arnold J Altman, Bruce C Bostrom, John C Breneman, Ria Hawks

J Clin Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Elizabeth Roman, Erin Cooney, Lauren Harrison, Olga Militano, Karen Wolownik, Ria Hawks

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and alternative medicine in pediatric oncology.
Janice Post-White, Ria G Hawks

Semin Oncol Nurs· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis